Stella Pharma (TSE:4888) EPS (Basic) : 円-24.66 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma EPS (Basic)?

Stella Pharma's basic earnings per share (Basic EPS) for the three months ended in Sep. 2024 was 円0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2024 was 円-24.66.

Stella Pharma's EPS (Diluted) for the three months ended in Sep. 2024 was 円0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円-24.66.

Stella Pharma's EPS without NRI for the three months ended in Sep. 2024 was 円0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2024 was -24.64.

During the past 3 years, the average EPS without NRI Growth Rate was 9.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Stella Pharma's highest 3-Year average EPS without NRI Growth Rate was 9.20% per year. The lowest was 4.30% per year. And the median was 8.30% per year.

Stella Pharma EPS (Basic) Historical Data

The historical data trend for Stella Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma EPS (Basic) Chart

Stella Pharma Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Basic)

Get a 7-Day Free Trial

-48.11

-32.90

-27.34

-26.97

-24.66

Stella Pharma Quarterly Data
	Mar19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
EPS (Basic)	Get a 7-Day Free Trial												-5.44	-4.51	-5.24	-9.47	-

Stella Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Stella Pharma's Basic EPS for the fiscal year that ended in Mar. 2024 is calculated as

Basic EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-763.749	-	0)	/	30.975
	=	-24.66

Stella Pharma's Basic EPS for the quarter that ended in Sep. 2024 is calculated as

Basic EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	32.732
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-24.66

Stella Pharma (TSE:4888) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Stella Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Stella Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043

Website

https://stella-pharma.co.jp

Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines